The Pfizer and the National Bleeding Disorders Foundation have partnered to launch the second round of the Education in the Era of Emerging Hemophilia Therapy initiative. This program invites proposals for independent medical education projects that empower both patients and healthcare providers with the knowledge to navigate evolving treatment options for hemophilia. The grant program […]
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: